Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

 

The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD
Launched: May 24, 2019

New Research on Therapies for Patients with Pulmonary Fibrosis
Launched: May 24, 2019


Spring 2019 — What are the Most Exciting Things Happening in Pulmonary Disease?
Launched: May 24, 2019

New Tools to Improve the Diagnosis of IPF vs Other ILDs
Launched: May 24, 2019


Biomarkers in IPF and Other ILDs

Launched: May 24, 2019

Connective Tissue Disease-Related ILD is Now in the Limelight
Launched: May 24, 2019


Patient-Centered Outcomes for Patients with IPF: Activity Monitoring
Launched: May 24, 2019

The Impact of Anticoagulation Use on IPF Patient Outcomes: A Warning About Warfarin
Launched: May 24, 2019


Which Patients with IPF Should be on Antifibrotics? The Value of Shared Decision Making
Launched: May 24, 2019

Dyspnea Assessment in Patients with IPF


Launched: May 24, 2019


Advanced Care Planning and Palliative Care Models for Patients with IPF
Launched: July 18, 2019

Download Audio | Transcript